$5.25
0.112.14%
At Close: -
$5.25
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Verve Therapeutics (NASDAQ:VERV) 주식, 내부자 거래 움직임
Verve Therapeutics: 내부자 매수 및 매도가 오늘 업데이트되었습니다.
기관 보유 주식
44.726M
기관 보유 비율
53.3%
| May 15, 2024 | Andrew Ashe | SEE REMARKS | 76K | $6.26 | $475.76K | BUY | 28.52% | 342.509K | May 14 | View |
| Apr 03, 2024 | Joan Nickerson | CHIEF ADMINISTRATIVE OFFICER | 1.801K | $8.24 | -$12.48K | SELL-OPTIONS | 26.26% | 8.659K | Apr 01 - Apr 02 | View |
| Dec 05, 2023 | Krishna Yeshwant | — | 1.8M | $10.00 | $18.00M | BUY | 42.25% | 6.060047M | Dec 01 | View |
| Dec 01, 2023 | Allison Dorval | CHIEF FINANCIAL OFFICER | 1.321K | $11.45 | -$6.34K | SELL-OPTIONS | 48.23% | 4.06K | Nov 29 | View |
| Dec 02, 2022 | Andrew Bellinger | CSO & CMO | -865 | $22.95 | -$19.85K | SELL | -11.54% | 6.629K | Dec 01 | View |
| Dec 01, 2022 | Allison Dorval | CHIEF FINANCIAL OFFICER | 1.321K | $22.10 | -$12.24K | SELL-OPTIONS | 152.72% | 2.186K | Nov 29 | View |
| Nov 08, 2022 | Krishna Yeshwant | DIRECTOR | -97.166K | $31.14 | -$1.51M | SELL | -2.23% | 4.260047M | Nov 04 | View |
| Nov 08, 2022 | GV GP LLCGV GP LPGV LPGV GP LLCGV GP LPGV LPAlphabet Inc | — | -145.749K | $31.14 | -$3.03M | SELL | -3.31% | 4.260047M | Nov 04 | View |
| Nov 04, 2022 | Krishna Yeshwant | DIRECTOR | -156.44K | $33.95 | -$2.66M | SELL | -3.50% | 4.30863M | Nov 02 - Nov 03 | View |
| Nov 04, 2022 | GV GP LLCGV GP LPGV LPGV GP LLCGV GP LPGV LPAlphabet Inc | — | -234.66K | $33.95 | -$5.31M | SELL | -5.16% | 4.30863M | Nov 02 - Nov 03 | View |
| Nov 02, 2022 | Krishna Yeshwant | DIRECTOR | -171.319K | $37.95 | -$3.25M | SELL | -3.76% | 4.38685M | Oct 31 - Nov 01 | View |
| Nov 02, 2022 | GV GP LLCGV GP LPGV LPGV GP LLCGV GP LPGV LPAlphabet Inc | — | -256.979K | $37.95 | -$6.50M | SELL | -5.53% | 4.38685M | Oct 31 - Nov 01 | View |
| Nov 01, 2022 | Andrew Bellinger | CSO & CMO | 0 | $20.69 | -$384.20K | SELL-OPTIONS | 0.00% | 6.629K | Oct 28 | View |
| Oct 05, 2022 | Sekar Kathiresan | CHIEF EXECUTIVE OFFICER | 0 | $17.52 | -$1.61M | SELL-OPTIONS | 0.00% | 398.836K | Oct 03 | View |
| Sep 27, 2022 | Andrew Bellinger | CSO & CMO | 0 | $18.41 | -$2.03M | SELL-OPTIONS | 0.00% | 6.629K | Sep 23 | View |
| Aug 11, 2022 | Sekar Kathiresan | CHIEF EXECUTIVE OFFICER | 0 | $15.64 | -$1.43M | SELL-OPTIONS | 0.00% | 398.836K | Aug 10 | View |
| Jul 22, 2022 | Andrew Bellinger | CSO & CMO | 0 | $18.14 | -$670.20K | SELL-OPTIONS | 0.00% | 6.629K | Jul 20 | View |
| Jul 21, 2022 | Sekar Kathiresan | CHIEF EXECUTIVE OFFICER | 0 | $15.64 | -$1.43M | SELL-OPTIONS | 0.00% | 398.836K | Jul 19 | View |
| Jul 15, 2022 | Andrew Bellinger | CSO & CMO | 0 | $13.19 | -$234.20K | SELL-OPTIONS | 0.00% | 6.629K | Jul 13 | View |
| Jul 14, 2022 | FMR LLC | 10% OWNER | -163K | $20.78 | -$3.39M | SELL | -22.22% | 570.729K | Jul 12 | View |
| Jul 06, 2022 | FMR LLC | 10% OWNER | -38.775K | $15.66 | -$607.22K | SELL | -4.77% | 773.729K | Jul 01 | View |
| Jul 01, 2022 | FMR LLC | 10% OWNER | -53.219K | $15.45 | -$822.48K | SELL | -6.45% | 772.504K | Jun 29 - Jun 30 | View |
| May 13, 2022 | Burt Adelman | DIRECTOR | 10K | $12.15 | $121.53K | BUY | 2.39% | 428.326K | May 12 | View |
| Mar 17, 2022 | Burt Adelman | DIRECTOR | 4K | $21.38 | $85.54K | BUY | 0.97% | 418.326K | Mar 15 | View |
| Mar 11, 2022 | FMR LLC | 10% OWNER | -3.971K | $29.01 | -$115.20K | SELL | -0.48% | 825.723K | Mar 09 | View |
| Feb 11, 2022 | FMR LLC | 10% OWNER | -13.19K | $29.46 | -$388.58K | SELL | -1.56% | 829.694K | Feb 09 | View |
| Feb 03, 2022 | FMR LLC | 10% OWNER | -35.574K | $29.04 | -$1.03M | SELL | -4.05% | 842.884K | Feb 01 | View |
| Jan 28, 2022 | FMR LLC | 10% OWNER | -158.836K | $31.12 | -$4.94M | SELL | -15.31% | 878.458K | Jan 26 - Jan 27 | View |
| Jan 06, 2022 | Sekar Kathiresan | CHIEF EXECUTIVE OFFICER | 0 | $20.64 | -$72.01K | SELL-OPTIONS | 0.00% | 487.533K | Jan 04 | View |
| Dec 29, 2021 | Sekar Kathiresan | CHIEF EXECUTIVE OFFICER | 0 | $20.78 | -$1.89M | SELL-OPTIONS | 0.00% | 487.533K | Dec 27 - Dec 28 | View |
| Dec 27, 2021 | Andrew Bellinger | CHIEF SCIENTIFIC OFFICER | 0 | $20.09 | -$558.27K | SELL-OPTIONS | 0.00% | 5K | Dec 22 | View |
| Dec 27, 2021 | Sekar Kathiresan | CHIEF EXECUTIVE OFFICER | 0 | $20.35 | -$4.32M | SELL-OPTIONS | 0.00% | 487.533K | Dec 22 - Dec 23 | View |
| Dec 06, 2021 | Andrew Ashe | SEE REMARKS | 4K | $32.10 | $128.42K | BUY | 2.40% | 170.722K | Dec 02 | View |
| Dec 06, 2021 | Burt Adelman | DIRECTOR | 4.7K | $31.34 | $147.30K | BUY | 1.15% | 414.326K | Dec 02 | View |
| Jun 23, 2021 | Redmile Group LLCJeremy Green | 10% OWNER | 1.93653M | $19.00 | $19.95M | BUY | ∞ | 1.93653M | Jun 21 | View |
| Jun 23, 2021 | Cormorant Asset Management LPBihua ChenCormorant Global Healthcare Master Fund LPCormorant Private Healthcare Fund III LP | DIRECTOR | 984.224K | $19.00 | $5.22M | BUY | ∞ | 984.224K | Jun 21 | View |
| Jun 22, 2021 | Logos Global Management LP | 10% OWNER | 813.265K | $19.00 | $7.03M | BUY | ∞ | 370K | Jun 21 | View |
| Jun 22, 2021 | Rock Springs Capital Management LPRock Springs Capital Master Fund LPRock Springs Capital LLC | 10% OWNER | 1.079224M | $19.00 | $7.03M | BUY | ∞ | 152.926K | Jun 21 | View |
| Jun 22, 2021 | Peter Haahr Chief Financial Officer of Novo Holdings A/S | 10% OWNER | 793.265K | $19.00 | $6.65M | BUY | ∞ | 793.265K | Jun 21 | View |
| Jun 22, 2021 | Casdin Partners Master Fund LP | 10% OWNER | 2.417596M | $19.00 | $20.90M | BUY | ∞ | 2.417596M | Jun 21 | View |
| Jun 21, 2021 | Margaret Beaudoin | VICE PRESIDENT, FINANCE | 1K | $19.00 | $19.00K | BUY | ∞ | 1K | Jun 21 | View |
| Jun 21, 2021 | Andrew Bellinger | CHIEF SCIENTIFIC OFFICER | 5K | $19.00 | $95.00K | BUY | ∞ | 5K | Jun 21 | View |
| Jun 21, 2021 | Sekar Kathiresan | CHIEF EXECUTIVE OFFICER | 2.5K | $19.00 | $47.50K | BUY | 0.52% | 487.533K | Jun 21 | View |
FAQ
인사이더 트레이딩은 합법인가요?
인사이더 트레이딩은 인사이더가 그 거래를 SEC에 보고하는 한 합법입니다. 불법 증권 거래는 인사이더가 위임된 의무를 위반하거나 거래를 보고하지 않을 때 발생합니다.
시장 조작의 몇 가지 예는 무엇인가요?
인사이더 트레이딩, 펌프 앤 덤프 계획, 프론트 러닝 및 워시 트레이드는 모두 시장 조작의 예입니다. 인사이더 자산 이동을 추적하는 투자자들은 이들 인사이더가 주식을 거래하는 이유에 대해 신중히 고려해야 합니다.
검색 내부자 거래 모든 주식에 대한
VERV 내부자 거래 뉴스
사람들이 또한 지켜본다
© 2024 Benzinga | All Rights Reserved